NCT04567134View on ClinicalTrials.gov

Clostridioides Difficile Infection - a Prospective Nationwide Epidemiologic Study in Korea

UnknownOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2022

Conditions
Clostridium Difficile Infection
Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Korean Center for Disease Control and Prevention

OTHER_GOV

collaborator

Pfizer

INDUSTRY

lead

Hanyang University Seoul Hospital

OTHER